PetMed Express, Inc. PETS
Set alert
1.21 USD +0.01 +0.83%
As of Nov 3, 2:05 PM ET
1.18 Day range 1.20
1.15 52-week range 4.10
- YTD
- -62.19%
- 1 year
- -50.41%
- Open
- 1.19
- Prev close
- 1.20
- Mkt cap
- 26.01M
- Vol
- 9.17K
- Avg vol
- 109.76K
- EPS
- -1.38
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.18
- High
- 1.20
- Forward P/E
- -161.67
- Beta
- 0.68
- Short ratio
- 3.46
- Inst. own
- 47.79%
- Dividend
- 0.00
- Ex-div date
- Aug 10, 2023
- 50-d avg
- 4.77
- 200-d avg
- 4.19
- 1y target
- 3.75
Analyst view
Price target (mean) 3.75 +209.9% upside
Now 1.21
- Target (low)
- 3.50
- Target (mean)
- 3.75
- Target (high)
- 4.00
Ratings (0m) 2 0 buy · 1 hold · 1 sell
- Strong buy0
- Buy0
- Hold1
- Sell1
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 60.00M | -8.1% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 62.00M | -6.8% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 244.40M | -13.1% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 252.28M | +3.2% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2024 | Lake Street | Downgrade | Buy | Hold |
| Jun 12, 2024 | Lake Street | Maintained | Buy | Buy |
| Jun 12, 2024 | Morgan Stanley | Maintained | Underweight | Underweight |
| Nov 16, 2023 | Morgan Stanley | Maintained | Underweight | Underweight |
| Oct 31, 2023 | Morgan Stanley | Maintained | Underweight | Underweight |
| Oct 19, 2023 | Morgan Stanley | Maintained | Underweight | Underweight |
| Jul 27, 2023 | Morgan Stanley | Reiterated | Underweight | Underweight |
| May 25, 2023 | Lake Street | Initiated | — | Buy |
| Mar 23, 2023 | Morgan Stanley | Maintained | — | Underweight |
| Nov 8, 2022 | Morgan Stanley | Maintained | — | Underweight |
| Jul 26, 2022 | Morgan Stanley | Maintained | — | Underweight |
| May 10, 2022 | Morgan Stanley | Maintained | — | Underweight |
| Jan 25, 2022 | Morgan Stanley | Maintained | — | Underweight |
| Jan 20, 2022 | Sidoti & Co. | Upgrade | Neutral | Buy |
| Nov 18, 2021 | Morgan Stanley | Initiated | — | Underweight |
| Oct 1, 2021 | Jefferies | Initiated | — | Hold |
| Jun 3, 2021 | Sidoti & Co. | Downgrade | Buy | Neutral |
| Mar 5, 2021 | Sidoti & Co. | Upgrade | Neutral | Buy |
| Aug 19, 2020 | Sidoti & Co. | Upgrade | Neutral | Buy |
| Feb 24, 2020 | Sidoti & Co. | Downgrade | Buy | Neutral |
| Oct 17, 2019 | Craig-Hallum | Maintained | — | Hold |
| Aug 16, 2019 | Craig-Hallum | Downgrade | Buy | Hold |
| Jul 9, 2018 | Craig-Hallum | Downgrade | Hold | Sell |
| Jun 15, 2018 | CL King | Initiated | — | Neutral |
| Aug 24, 2017 | Sidoti & Co. | Upgrade | Neutral | Buy |
| Jul 24, 2017 | Northcoast Research | Upgrade | Neutral | Buy |
| Jul 11, 2017 | Craig-Hallum | Downgrade | Buy | Hold |
| May 9, 2016 | Craig-Hallum | Upgrade | Sell | Hold |
| Feb 3, 2016 | Credit Suisse | Initiated | — | Underperform |
| May 1, 2014 | Northcoast Research | Downgrade | Buy | Neutral |